INDIANAPOLIS — As teams kicked off on-track preparation for next month’s Indianapolis 500, it was a trio of former winners — including the two-time-defending race-winner — atop the timing ...

The COPD approval marks the fifth Nucala has received from the FDA, following green lights in severe asthma, chronic rhinosinusitis with nasal polyps, eosinophilic granulomatosis with polyangiitis and ...